<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Details for gene set HALLMARK_ALLOGRAFT_REJECTION[GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.gsea-msigdb.org/gsea/images/icon_16x16.png' rel='shortcut icon'></head><body><div class='keyValTable'><table cols='2' border='0'><th class='keyValTable'></th><th class='keyValTable'></th><tr><td>Dataset</td><td>EnterocytesDKOvsEnterocytesWT_PreRanked_collapsed</td></tr><tr><td>Phenotype</td><td>NoPhenotypeAvailable</td></tr><tr><td>Upregulated in class</td><td>na_neg</td></tr><tr><td>GeneSet</td><td>HALLMARK_ALLOGRAFT_REJECTION</td></tr><tr><td>Enrichment Score (ES)</td><td>-0.47525334</td></tr><tr><td>Normalized Enrichment Score (NES)</td><td>-1.6451243</td></tr><tr><td>Nominal p-value</td><td>0.027855154</td></tr><tr><td>FDR q-value</td><td>0.06123735</td></tr><tr><td>FWER p-Value</td><td>0.407</td></tr><caption class='table'>Table: GSEA Results Summary</caption></table></div><br><div class='image'><img name='enplot_HALLMARK_ALLOGRAFT_REJECTION' src='enplot_HALLMARK_ALLOGRAFT_REJECTION_327.png'><br><br><caption>Fig 1: Enrichment plot: HALLMARK_ALLOGRAFT_REJECTION &nbsp&nbsp <br> Profile of the Running ES Score & Positions of GeneSet Members on the Rank Ordered List</caption></div><br><div class='richTable'><table cols='7' border='1'><th class='richTable'></th><th class='richTable'>SYMBOL</th><th class='richTable'>TITLE</th><th class='richTable'>RANK IN GENE LIST</th><th class='richTable'>RANK METRIC SCORE</th><th class='richTable'>RUNNING ES</th><th class='richTable'>CORE ENRICHMENT</th><tr><td class='lessen'>1</td><td><a href='https://ensembl.org/Search/Results?q=RPL39'>RPL39</a></td><td>ribosomal protein L39 [Source:HGNC Symbol;Acc:HGNC:10350]</td><td>69</td><td>0.479</td><td>-0.0218</td><td>No</td></tr><tr><td class='lessen'>2</td><td><a href='https://ensembl.org/Search/Results?q=NOS2'>NOS2</a></td><td>nitric oxide synthase 2 [Source:HGNC Symbol;Acc:HGNC:7873]</td><td>104</td><td>0.414</td><td>-0.0145</td><td>No</td></tr><tr><td class='lessen'>3</td><td><a href='https://ensembl.org/Search/Results?q=RPS19'>RPS19</a></td><td>ribosomal protein S19 [Source:HGNC Symbol;Acc:HGNC:10402]</td><td>106</td><td>0.410</td><td>0.0260</td><td>No</td></tr><tr><td class='lessen'>4</td><td><a href='https://ensembl.org/Search/Results?q=HLA-A'>HLA-A</a></td><td>major histocompatibility complex, class I, A [Source:HGNC Symbol;Acc:HGNC:4931]</td><td>201</td><td>0.289</td><td>-0.0405</td><td>No</td></tr><tr><td class='lessen'>5</td><td><a href='https://ensembl.org/Search/Results?q=CCND2'>CCND2</a></td><td>cyclin D2 [Source:HGNC Symbol;Acc:HGNC:1583]</td><td>208</td><td>0.282</td><td>-0.0180</td><td>No</td></tr><tr><td class='lessen'>6</td><td><a href='https://ensembl.org/Search/Results?q=TAP2'>TAP2</a></td><td>transporter 2, ATP binding cassette subfamily B member [Source:HGNC Symbol;Acc:HGNC:44]</td><td>364</td><td>-0.279</td><td>-0.1477</td><td>No</td></tr><tr><td class='lessen'>7</td><td><a href='https://ensembl.org/Search/Results?q=STAT1'>STAT1</a></td><td>signal transducer and activator of transcription 1 [Source:HGNC Symbol;Acc:HGNC:11362]</td><td>505</td><td>-0.329</td><td>-0.2570</td><td>No</td></tr><tr><td class='lessen'>8</td><td><a href='https://ensembl.org/Search/Results?q=IFNGR2'>IFNGR2</a></td><td>interferon gamma receptor 2 [Source:HGNC Symbol;Acc:HGNC:5440]</td><td>608</td><td>-0.391</td><td>-0.3213</td><td>No</td></tr><tr><td class='lessen'>9</td><td><a href='https://ensembl.org/Search/Results?q=TAP1'>TAP1</a></td><td>transporter 1, ATP binding cassette subfamily B member [Source:HGNC Symbol;Acc:HGNC:43]</td><td>663</td><td>-0.426</td><td>-0.3332</td><td>No</td></tr><tr><td class='lessen'>10</td><td><a href='https://ensembl.org/Search/Results?q=IRF8'>IRF8</a></td><td>interferon regulatory factor 8 [Source:HGNC Symbol;Acc:HGNC:5358]</td><td>667</td><td>-0.429</td><td>-0.2928</td><td>No</td></tr><tr><td class='lessen'>11</td><td><a href='https://ensembl.org/Search/Results?q=IL18'>IL18</a></td><td>interleukin 18 [Source:HGNC Symbol;Acc:HGNC:5986]</td><td>847</td><td>-0.614</td><td>-0.4130</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>12</td><td><a href='https://ensembl.org/Search/Results?q=HLA-DMA'>HLA-DMA</a></td><td>major histocompatibility complex, class II, DM alpha [Source:HGNC Symbol;Acc:HGNC:4934]</td><td>909</td><td>-0.726</td><td>-0.4016</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>13</td><td><a href='https://ensembl.org/Search/Results?q=HLA-DMB'>HLA-DMB</a></td><td>major histocompatibility complex, class II, DM beta [Source:HGNC Symbol;Acc:HGNC:4935]</td><td>914</td><td>-0.737</td><td>-0.3310</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>14</td><td><a href='https://ensembl.org/Search/Results?q=PSMB10'>PSMB10</a></td><td>proteasome 20S subunit beta 10 [Source:HGNC Symbol;Acc:HGNC:9538]</td><td>927</td><td>-0.772</td><td>-0.2650</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>15</td><td><a href='https://ensembl.org/Search/Results?q=HLA-DQA1'>HLA-DQA1</a></td><td>major histocompatibility complex, class II, DQ alpha 1 [Source:HGNC Symbol;Acc:HGNC:4942]</td><td>993</td><td>-1.512</td><td>-0.1781</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>16</td><td><a href='https://ensembl.org/Search/Results?q=CD74'>CD74</a></td><td>CD74 molecule [Source:HGNC Symbol;Acc:HGNC:1697]</td><td>995</td><td>-1.777</td><td>0.0010</td><td bgcolor='#CCFFCC'>Yes</td></tr><caption class='table'>Table: GSEA details&nbsp<a href='HALLMARK_ALLOGRAFT_REJECTION.tsv'>[plain text format]</a></caption></table></div><br><div class='image'><img name='gset_rnd_es_dist' src='gset_rnd_es_dist_328.png'><br><br><caption>Fig 2: HALLMARK_ALLOGRAFT_REJECTION: Random ES distribution &nbsp&nbsp <br> Gene set null distribution of ES for <b>HALLMARK_ALLOGRAFT_REJECTION</b></caption></div><br></body></html>